Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Liver Diseases

Free Subscription 09.07.2018 1 Am J Gastroenterol 5 Anticancer Res 1 Biochem Biophys Res Commun 1 BMC Cancer 1 BMC Gastroenterol 2 Cancer Res 1 Clin Res Hepatol Gastroenterol 1 Dig Dis 1 Eur Radiol 1 Gut 1 Hepatology 1 J Gastroenterol Hepatol 1 J Hepatol 2 N Engl J Med 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Gastroenterol

1. ADEBAYO D, Neong SF, Wong F
   Refractory Ascites in Liver Cirrhosis.
   Am J Gastroenterol. 2018 Jul 5. pii: 10.1038/s41395-018-0185.
   PubMed     Text format     Abstract available
   
   

   
   Anticancer Res

2. KOGA Y, Beppu T, Miyata T, Kitano Y, et al
   Predicting Poorly Differentiated Hepatocellular Carcinoma that Meets the Milan Criteria.
   Anticancer Res. 2018;38:4093-4099.
   PubMed     Text format     Abstract available
   
   
3. UCHIYAMA H, Komatsu KI, Nakata A, Sato K, et al
   Global Liver Gene Expression Analysis on a Murine Hepatic Steatosis Model Treated with Mulberry (Morus alba L.) Leaf Powder.
   Anticancer Res. 2018;38:4305-4311.
   PubMed     Text format     Abstract available
   
   
4. NOH CK, Wang HJ, Kim CM, Kim J, et al
   EpCAM as a Predictive Marker of Tumor Recurrence and Survival in Patients Who Underwent Surgical Resection for Hepatocellular Carcinoma.
   Anticancer Res. 2018;38:4101-4109.
   PubMed     Text format     Abstract available
   
   
5. TSAI TJ, Chao WY, Chen CC, Chen YJ, et al
   Gelsolin-like Actin-capping Protein (CapG) Overexpression in the Cytoplasm of Human Hepatocellular Carcinoma, Associated with Cellular Invasion, Migration and Tumor Prognosis.
   Anticancer Res. 2018;38:3943-3950.
   PubMed     Text format     Abstract available
   
   
6. SCHMIDT TM, Liu LI, Abraham IE, Uy AB, et al
   Efficacy and Safety of Sorafenib in a Racially Diverse Patient Population with Advanced Hepatocellular Carcinoma.
   Anticancer Res. 2018;38:4027-4034.
   PubMed     Text format     Abstract available
   
   

   
   Biochem Biophys Res Commun

7. HU H, Yang L, Li L, Zeng C, et al
   Long non-coding RNA KCNQ1OT1 modulates oxaliplatin resistance in hepatocellular carcinoma through miR-7-5p/ ABCC1 axis.
   Biochem Biophys Res Commun. 2018 Jun 29. pii: S0006-291X(18)31488.
   PubMed     Text format     Abstract available
   
   

   
   BMC Cancer

8. OZAKI Y, Shindoh J, Miura Y, Nakajima H, et al
   Serial pseudoprogression of metastatic malignant melanoma in a patient treated with nivolumab: a case report.
   BMC Cancer. 2017;17:778.
   PubMed     Text format     Abstract available
   
   

   
   BMC Gastroenterol

9. SHARMA A, Poddar U, Agnihotry S, Phadke SR, et al
   Spectrum of genomic variations in Indian patients with progressive familial intrahepatic cholestasis.
   BMC Gastroenterol. 2018;18:107.
   PubMed     Text format     Abstract available
   
   

   
   Cancer Res

10. LI Y, Lin S, Li L, Tang Z, et al
    PDSS2 deficiency induces hepatocarcinogenesis by decreasing mitochondrial respiration and reprogramming glucose metabolism.
    Cancer Res. 2018 Jul 2. pii: 0008-5472.CAN-17-2172.
    PubMed     Text format     Abstract available
    
    
11. MAKINO Y, Hikita H, Kodama T, Shigekawa M, et al
    CTGF mediates tumor-stroma interactions between hepatoma cells and hepatic stellate cells to accelerate HCC progression.
    Cancer Res. 2018 Jul 2. pii: 0008-5472.CAN-17-3844.
    PubMed     Text format     Abstract available
    
    

    
    Clin Res Hepatol Gastroenterol

12. MA X, Sun D, Li C, Ying J, et al
    Statin use and virus-related cirrhosis: A systemic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2017 Aug 30. pii: S2210-7401(17)30180.
    PubMed     Text format     Abstract available
    
    

    
    Dig Dis

13. FURUTA M, Moriguchi M, Okuda K, Kataoka S, et al
    Impact of Insufficient Response with an Increase in Tumor Number in Predicting Transcatheter Arterial Chemoembolization Refractoriness for Hepatocellular Carcinoma.
    Dig Dis. 2018 Jul 3:1-10. doi: 10.1159/000489488.
    PubMed     Text format     Abstract available
    
    

    
    Eur Radiol

14. SEO N, Kim MS, Park MS, Choi JY, et al
    Optimal criteria for hepatocellular carcinoma diagnosis using CT in patients undergoing liver transplantation.
    Eur Radiol. 2018 Jul 4. pii: 10.1007/s00330-018-5557.
    PubMed     Text format     Abstract available
    
    

    
    Gut

15. LIM CJ, Lee YH, Pan L, Lai L, et al
    Multidimensional analyses reveal distinct immune microenvironment in hepatitis B virus-related hepatocellular carcinoma.
    Gut. 2018 Jul 3. pii: gutjnl-2018-316510. doi: 10.1136/gutjnl-2018-316510.
    PubMed     Text format     Abstract available
    
    

    
    Hepatology

16. RUSSO N, Brown RS Jr, Shen NT, Pisa JF, et al
    Hepatology highlights.
    Hepatology. 2018;68:1-3.
    PubMed     Text format    
    
    

    
    J Gastroenterol Hepatol

17. WANG HW, Lai HC, Hu TH, Su WP, et al
    Modified FIB-4 index stratifies hepatocellular carcinoma risk in chronic hepatitis B patients on entecavir therapy.
    J Gastroenterol Hepatol. 2018 Jul 3. doi: 10.1111/jgh.14372.
    PubMed     Text format     Abstract available
    
    

    
    J Hepatol

18. TANDON P, Ismond KP, Riess K, Duarte-Rojo A, et al
    Exercise in Cirrhosis: Translating evidence and experience to practice.
    J Hepatol. 2018 Jun 28. pii: S0168-8278(18)32170.
    PubMed     Text format     Abstract available
    
    

    
    N Engl J Med

19. BROCK PR, Maibach R, Childs M, Rajput K, et al
    Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss.
    N Engl J Med. 2018;378:2376-2385.
    PubMed     Text format     Abstract available
    
    
20. ABOU-ALFA GK, Meyer T, Cheng AL, El-Khoueiry AB, et al
    Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma.
    N Engl J Med. 2018;379:54-63.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

21. WATTANAVANITCHAKORN S, Rojvirat P, Chavalit T, MacDonald MJ, et al
    CCAAT-enhancer binding protein-alpha (C/EBPalpha) and hepatocyte nuclear factor 4alpha (HNF4alpha) regulate expression of the human fructose-1,6-bisphosphatase 1 (FBP1) gene in human hepatocellular carcinoma HepG2 cells.
    PLoS One. 2018;13:e0194252.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: